Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD.

Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5.

PMID:
24908205
2.

Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.

Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ophthalmology. 2013 Sep;120(9):1852-9. doi: 10.1016/j.ophtha.2013.01.069. Epub 2013 May 21.

3.

Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.

Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group.

Ophthalmology. 2013 Aug;120(8):1571-9. doi: 10.1016/j.ophtha.2013.01.025. Epub 2013 Apr 16.

4.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10.

5.

Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ocul Immunol Inflamm. 2012 Apr;20(2):104-12. doi: 10.3109/09273948.2011.647228.

6.

Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT; Multicenter Uveitis Steroid Treatment-MUST Trial Research Group.

Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1169-76. doi: 10.1167/iovs.11-8259. Print 2012 Mar.

7.

Chronic central serous chorioretinopathy responsive to rifampin.

Ravage ZB, Packo KH, Creticos CM, Merrill PT.

Retin Cases Brief Rep. 2012 Winter;6(1):129-32. doi: 10.1097/ICB.0b013e3182235561.

PMID:
25390732
8.

Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.

Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH; MUST Trial Research Group.

Ocul Immunol Inflamm. 2011 Aug;19(4):267-74. doi: 10.3109/09273948.2011.583376.

9.

Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus.

Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD; Diabetic Retinopathy Clinical Research Network.

Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6168-73. doi: 10.1167/iovs.11-7321.

10.

Cytomegalovirus acute retinal necrosis in an immunocompetent patient after sub-tenon triamcinolone injection.

Babiuch AS, Ravage ZB, Merrill PT.

Retin Cases Brief Rep. 2010 Fall;4(4):364-5. doi: 10.1097/ICB.0b013e3181b5ef2a.

PMID:
25390918
11.

Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.

Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, Armstrong JR; Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2009 Sep;127(9):1168-74. doi: 10.1001/archophthalmol.2009.198.

PMID:
19752426
12.

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network.

Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. doi: 10.1016/j.ophtha.2008.06.015. Epub 2008 Jul 26.

13.

Diagnostic and therapeutic challenges. Acute retinal necrosis syndrom.

Park SS, Holz HA, Ravage ZB, Merrill PT, Nguyen QD.

Retina. 2008 Apr;28(4):660-4. doi: 10.1097/IAE.0b013e3181631987. No abstract available.

PMID:
18398372
14.

Magnetic resonance imaging of diffuse cerebral vasculitis associated with acute retinal necrosis.

Chung GW, Thulborn KR, Pulido JS, Merrill PT, Tessler HH.

Arch Ophthalmol. 2004 Nov;122(11):1719-20. No abstract available.

PMID:
15534140
15.

Clinical characteristics of central serous chorioretinopathy in women.

Perkins SL, Kim JE, Pollack JS, Merrill PT.

Ophthalmology. 2002 Feb;109(2):262-6.

PMID:
11825806
16.

Perfluoro-N-octane (PFO) in the repair of complicated retinal detachments due to severe proliferative diabetic retinopathy.

Maturi RK, Merrill PT, Lomeo MD, Diaz-Rohena R, Khan M, Lambert HM.

Ophthalmic Surg Lasers. 1999 Nov-Dec;30(9):715-20.

PMID:
10574492
17.

Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration.

Merrill PT, LoRusso FJ, Lomeo MD, Saxe SJ, Khan MM, Lambert HM.

Ophthalmology. 1999 Apr;106(4):782-9.

PMID:
10201603
18.

Uveitis in the southeastern United States.

Merrill PT, Kim J, Cox TA, Betor CC, McCallum RM, Jaffe GJ.

Curr Eye Res. 1997 Sep;16(9):865-74.

PMID:
9288447
19.
20.

New and recurrent tumors in germinal retinoblastoma: is there a treatment effect?

Merrill PT, Buckley EG, Halperin EC.

Ophthalmic Genet. 1996 Sep;17(3):115-8.

PMID:
8905852
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk